MedPath

Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease: The MICORDIS-study

Recruiting
Conditions
on-obstructive coronary artery diseaseCoronary microvascular dysfunctionCapillary recruitmentCapillary rarefaction
Registration Number
NL-OMON23861
Lead Sponsor
Amsterdam UMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
56
Inclusion Criteria

Patient group:

- Age > 40 years

Exclusion Criteria

- age > 80 years

- Obstructive coronary artery disease, defined as 50% or more obstruction of any coronary artery

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the difference in myocardial blood volume (MBV) between non-obstructive coronary artery disease patients and healthy controls. We compare MBV between groups at baseline, during hyperinsulinemia and during increased cardiac contraction.<br>MBV is measured using myocardial contrast echocardiography. Hyperinsulinemia is induced by a two hour hyperinsulinemic euglymic-clamp and cardiac contraction is increased via the infusion of dobutamine.
Secondary Outcome Measures
NameTimeMethod
1. MBV, MBF, ÄMBV, baseline characteristics, cardiovascular risk factors, questionnaire results, blood parameters and measurement indexes compared between males and females from the patient and control group.<br /><br>2. Differences in MBV between baseline and after HE-clamp of the patient and control group. Differences in MBV between baseline and after dobutamine stress of the patient and control group.<br /><br>3. Baseline characteristics, cardiovascular risk factors, questionnaire results and measurement indexes compared between the patient and control group.<br /><br>4. MBV, MBF and ÄMBV compared between insulin resistant subjects and non-insulin resistant subjects.<br /><br>5. Correlation between MBV measured with MCE and MBV measured with CMR.<br /><br>6. Protein expression and phosphorylation of microvascular endothelial cells compared between the patient and control group.
© Copyright 2025. All Rights Reserved by MedPath